Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial

被引：0
|
作者：
Ju Yup Lee
Nayoung Kim
Kyung Sik Park
Hyun Jin Kim
Seon Mee Park
Gwang Ho Baik
Ki-Nam Shim
Jung Hwan Oh
Suck Chei Choi
Sung Eun Kim
Won Hee Kim
Seon-Young Park
Gwang Ha Kim
Bong Eun Lee
Yunju Jo
Su Jin Hong
机构：
[1] Seoul National University Bundang Hospital,Department of Internal Medicine
[2] Keimyung University School of Medicine,Department of Internal Medicine
[3] Gyeongsang National University School of Medicine,Department of Internal Medicine and Institute of Health Science
[4] College of Medicine,Department of Internal Medicine
[5] Chungbuk National University,Department of Internal Medicine
[6] Hallym University College of Medicine,Department of Internal Medicine
[7] Chuncheon Sacred Heart Hospital,Departments of Internal Medicine, College of Medicine
[8] Ewha Womans University School of Medicine,Department of Internal Medicine
[9] The Catholic University of Korea,Department of Internal Medicine
[10] Wonkwang University School of Medicine,Digestive Disease Center, CHA Bundang Medical Center
[11] Kosin University College of Medicine,Department of Internal Medicine
[12] CHA University,Department of Internal Medicine
[13] Chonnam National University Medical School,Department of Internal Medicine
[14] Pusan National University School of Medicine and Biomedical Research Institute,Department of Internal Medicine and Research Institute
[15] Pusan National University Hospital,undefined
[16] Eulji General Hospital,undefined
[17] Eulji University School of Medicine,undefined
[18] Soonchunhyang University College of Medicine,undefined
来源：
BMC Gastroenterology | / 16卷
关键词：
Eradication; Amoxicillin; Tetracycline; Bismuth; Quadruple;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial
    Suo Baojun
    Tian Xueli
    Zhang Hua
    Lu Haoping
    Li Cailing
    Zhang Yuxin
    Ren Xinlu
    Yao Xingyu
    Zhou Liya
    Song Zhiqiang
    中华医学杂志英文版, 2023, 136 (08)
  • [32] Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy
    Zhang, Wei
    Chen, Qi
    Liang, Xiao
    Liu, Wenzhong
    Xiao, Shudong
    Graham, David Y.
    Lu, Hong
    GUT, 2015, 64 (11) : 1715 - 1720
  • [33] Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori
    Lahaie, R
    Farley, A
    Dallaire, C
    Archambault, A
    Fallone, CA
    Ponich, T
    Hunt, R
    Oravec, M
    Whitsitt, P
    Van Zanten, SV
    Marcon, N
    Bailey, R
    Dumont, A
    Nguyen, B
    Desrochers, S
    Spénard, J
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2001, 15 (09): : 581 - 585
  • [34] The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication
    Sue, Soichiro
    Kuwashima, Hirofumi
    Iwata, Yuri
    Oka, Hiroyuki
    Arima, Isao
    Fukuchi, Takehide
    Sanga, Katsuyuki
    Inokuchi, Yasuhiro
    Ishii, Yuniba
    Kanno, Masatomo
    Terada, Masahiro
    Amano, Hitoshi
    Naito, Makoto
    Iwase, Shigeru
    Okazaki, Hiroshi
    Komatsu, Kazuto
    Kokawa, Atsushi
    Kawana, Ichiro
    Morimoto, Manabu
    Saito, Toshifumi
    Kunishi, Yosuke
    Ikeda, Akihiko
    Takahashi, Daisuke
    Miwa, Haruo
    Sasaki, Tomohiko
    Tamura, Toshihide
    Kondo, Masaaki
    Shibata, Wataru
    Maeda, Shin
    INTERNAL MEDICINE, 2017, 56 (11) : 1277 - 1285
  • [35] Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial
    Huang, Yu
    Chen, Jinnan
    Ding, Zhaohui
    Chen, Xi
    Liang, Xiao
    Zeng, Xin
    Xu, Fei
    Han, Yuehua
    Lu, Hong
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (07) : 633 - 641
  • [36] A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Manzoli, Lamberto
    Marzio, Leonardo
    HELICOBACTER, 2015, 20 (05) : 390 - 396
  • [37] Eradication of Helicobacter pylori: a prospective comparative randomized trial of standard versus optimized quadruple therapy
    Souissi, Salma
    Makni, Cyrine
    Chaieb, Basma
    Jarraya, Amine
    Toulgui, Nadia
    Jmal, Lobna
    Mlika, Mouna
    Fendri, Chadlia
    Bouchoucha, Mohamed
    Razgallah, Rabie
    Ammar, Leila Belhadj
    Bousnina, Olfa
    Mezni, Fawzi
    Jmal, Awatef
    Kallel, Lamia
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [38] Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study
    Xiang Peng
    Huang-wei Chen
    Yu Wan
    Pei-zhu Su
    Jing Yu
    Jun-jun Liu
    Yi Lu
    Min Zhang
    Jia-Yin Yao
    Min Zhi
    Clinical and Experimental Medicine, 2023, 23 : 4011 - 4019
  • [39] First-line Bismuth-containing Five-day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication
    Dolapcioglu, Can
    Sayiner, Mehmet
    Akkus, Esra Elif
    Kural, Abdulaziz
    Dolapcioglu, Hatice
    Dabak, Resat
    Ahishali, Emel
    HELICOBACTER, 2016, 21 (02) : 100 - 105
  • [40] Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial
    Lim, Hyun
    Bang, Chang Seok
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    MEDICINE, 2018, 97 (46)
12345